Obesity Market Research Reports & Industry Analysis
Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.
The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.
According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.
Obesity Industry Research & Market Reports
-
Body Fat Reduction Procedures Market Size - By Procedure [Surgical (Liposuction, Abdominoplasty), Non-surgical (Laser, RF, Cryolipolysis)], Gender (Female, Male), Service Provider - Global Forecast (2024 - 2032)
... to expand at 9.3% CAGR from 2024-2032 attributed to the influence of social media and celebrity culture. Platforms like Instagram and TikTok showcase idealized body images, prompting individuals to pursue fat-reduction treatments to emulate their ... Read More
-
Obesity Treatment Market by Drugs (Appetite Suppressants, Combination Drugs, Malabsorption & Satiety Drugs), Surgery & Devices (Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) - Global Forecast 2024-2030
... was estimated at USD 17.14 billion in 2023 and expected to reach USD 18.88 billion in 2024, at a CAGR 10.24% to reach USD 33.93 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Global Forecast 2024-2030
... reach USD 22.14 billion in 2024, at a CAGR 5.82% to reach USD 31.12 billion by 2030. Global Lifestyle Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lifestyle Drugs ... Read More
-
Anti-Obesity Drugs Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.09 billion in 2024, at a CAGR 6.86% to reach USD 6.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Drugs ... Read More
-
Polycystic Ovarian Syndrome Treatment Market by Drug Class (Anti-Depressants, Anti-Obesity, Insulin Sensitizing Agents), Surgery (Laparoscopic Ovarian Drilling, Ovarian Wedge Resection), Distribution Channel - Global Forecast 2024-2030
... at USD 3.25 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 6.63% to reach USD 5.09 billion by 2030. Global Polycystic Ovarian Syndrome Treatment Market FPNV Positioning Matrix ... Read More
-
Obesity Surgery Devices Market by Type (Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices), Procedure (Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass) - Global Forecast 2024-2030
... estimated at USD 4.07 billion in 2023 and expected to reach USD 4.39 billion in 2024, at a CAGR 7.91% to reach USD 6.94 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Anti-obesity Prescription Drugs Market by Drug Class (Bupropion & Naltrexone, Liraglutide, Lorcaserin), Age Group (Adult, Pediatric), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 6.71 billion in 2024, at a CAGR 8.12% to reach USD 10.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-obesity Prescription ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
-
Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Global Forecast 2024-2030
... million in 2024, at a CAGR 17.53% to reach USD 1,887.63 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nutrigenomics Market. It offers a comprehensive assessment of vendors, ... Read More
-
Endoluminal Suturing Devices Market by Application (Bariatric Surgery, Gastroesophageal Reflux Disease Surgery, Gastrointestinal Surgery), End-User (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 48.44 billion in 2024, at a CAGR 12.86% to reach USD 100.19 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Endoluminal ... Read More
-
Global Smart Weight, Body Composition, and BMI Scales Market 2024-2028
... during the forecast period. The report on the smart weight, body composition, and BMI scales market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering ... Read More
-
Global Long-term Treatment Drugs for Obesity Market Growth 2023-2029
... demand in downstream market, the Long-term Treatment Drugs for Obesity is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
North America Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The North America endothelial dysfunction market is expected to grow from US$ 951.83 million in 2022 ... Read More
-
Middle East & Africa Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The Middle East & Africa endothelial dysfunction market is expected to grow from US$ ... Read More
-
Europe Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The Europe endothelial dysfunction market is expected to grow from US$ 611.28 million in 2022 to US$ ... Read More
-
Growth Opportunities in Obesity Drugs and Delivery Platforms
... delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to 30 (or 27kg/m2) are classified as obese and may or ... Read More
-
Antiobesity Global Market Report 2024
... Hoffmann-La Roche AG; GlaxoSmithKline plc; Boehringer Ingelheim GmbH; Pfizer Inc.; Merck & Co. Inc. Antiobesity Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they ... Read More
-
Weight Monitoring And Body Temperature Monitoring Devices And Equipment Global Market Report 2024
... Temperature Monitoring Devices; Wearable Continuous Monitoring Thermometers; Temperature Monitoring Sensors & Smart Temperature Patches 3) By End User: Hospitals & Clinics; Home Settings; Ambulatory Surgical Centers Covering: Philips Healthcare; Medtronic plc; GE HealthCare Technologies Inc.; ... Read More
-
Global Market for Anti-obesity Drugs
... 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading ... Read More
-
Obesity Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Increasing Incidence of Obesity and Rising Healthcare Spending Fueling Market Expansion The global Obesity Surgery Devices Market is on the brink of significant growth, with a projected valuation of approximately US$ 3 Billion by the ... Read More
-
Patient Engagement Solutions Market based on by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) & Regional Outlook– Global Forecast up to 2030
... 2030 In order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To ... Read More
-
Health and Wellness in Australia
... a range of claims such as natural, organic, good source of minerals/vitamins, no sugar/no added sugar (particularly in beverages), low fat and high protein/fibre. Euromonitor International's Health and Wellness in Australia report tracks the developments ... Read More
-
Body Composition Analyzers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 1,149.6 Million by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2022-2028. A body composition analyzer (BCA) is an equipment that is used to measure weight, body fat, water percentage, BMR, DCI, ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
Research Assistance
